Gregg Reimportation Plan Is FDA-Approved, Sponsors Say
This article was originally published in The Pink Sheet Daily
Executive Summary
Sen. Judd Gregg's (R-N.H.) reimportation bill has received the assent of FDA officials, the Health Committee chairman declared at the measure's unveiling June 2
You may also be interested in...
Rx Import Bills Do Not Have Adequate Funding For FDA, Agency Says
Senate bills "do not go far enough" in allowing FDA to assure safety and efficacy of imported drugs, FDA's Hubbard tells Judiciary Committee hearing. Senate Health Committee will mark up Sen. Gregg's import bill July 21.
Rx Import Bills Do Not Have Adequate Funding For FDA, Agency Says
Senate bills "do not go far enough" in allowing FDA to assure safety and efficacy of imported drugs, FDA's Hubbard tells Judiciary Committee hearing. Senate Health Committee will mark up Sen. Gregg's import bill July 21.
FDA Import Program Would Need Funds To Inspect All U.S. Pharmacies, Agency Maintains
The pharmacy industry has told FDA all U.S. pharmacies will need to participate in a drug importation program to stay in business, so up to 55,000 pharmacies would have to be inspected, FDA's McGinnis says. "Draconian" penalties for non-complying drug manufacturers would ensure ample flow of drugs from Canada, he says.